The Cancer Letter

Inside information on cancer research and drug development

Vol.
35
No.
11
November 30, 2012Nov 30, 2012
Free
DOWNLOAD THE PDF

SBRT Delivers Higher Overall Survival Rates Compared to Conventional Radiation Therapy

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

Abraxane and Gemcitabine Improves Overall Survival

Study Uncovers New Mechanism In Class of Chemotherapy Drugs

Adjuvant Radiation Treatment Shows Improved Survival In Elderly, Early-Stage Patients

Genetic Test Identifies Patients With High Risk of Mortality

Memantine Can Delay Onset Of Cognitive Function Decline

Doxepin Rinse Reduces Pain In Radiation Therapy Patients

Zaltrap Receives Positive Opinion For European Market From CHMP

NCI-Approved CTEP Trials For the Month of November

Login

Looking for IP Login?